• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

shinyDeepDR:一款用户友好的R Shiny应用程序,用于使用深度学习预测抗癌药物反应。

shinyDeepDR: A user-friendly R Shiny app for predicting anti-cancer drug response using deep learning.

作者信息

Wang Li-Ju, Ning Michael, Nayak Tapsya, Kasper Michael J, Monga Satdarshan P, Huang Yufei, Chen Yidong, Chiu Yu-Chiao

机构信息

Cancer Therapeutics Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA 15232, USA.

Greehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

出版信息

Patterns (N Y). 2024 Jan 12;5(2):100894. doi: 10.1016/j.patter.2023.100894. eCollection 2024 Feb 9.

DOI:10.1016/j.patter.2023.100894
PMID:38370127
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10873157/
Abstract

Advancing precision oncology requires accurate prediction of treatment response and accessible prediction models. To this end, we present shinyDeepDR, a user-friendly implementation of our innovative deep learning model, DeepDR, for predicting anti-cancer drug sensitivity. The web tool makes DeepDR more accessible to researchers without extensive programming experience. Using shinyDeepDR, users can upload mutation and/or gene expression data from a cancer sample (cell line or tumor) and perform two main functions: "Find Drug," which predicts the sample's response to 265 approved and investigational anti-cancer compounds, and "Find Sample," which searches for cell lines in the Cancer Cell Line Encyclopedia (CCLE) and tumors in The Cancer Genome Atlas (TCGA) with genomics profiles similar to those of the query sample to study potential effective treatments. shinyDeepDR provides an interactive interface to interpret prediction results and to investigate individual compounds. In conclusion, shinyDeepDR is an intuitive and free-to-use web tool for anti-cancer drug screening.

摘要

推进精准肿瘤学需要准确预测治疗反应以及可获取的预测模型。为此,我们展示了shinyDeepDR,这是我们用于预测抗癌药物敏感性的创新深度学习模型DeepDR的用户友好型实现。该网络工具使没有丰富编程经验的研究人员更容易使用DeepDR。使用shinyDeepDR,用户可以上传癌症样本(细胞系或肿瘤)的突变和/或基因表达数据,并执行两个主要功能:“查找药物”,可预测样本对265种已批准和正在研究的抗癌化合物的反应;以及“查找样本”,可在癌症细胞系百科全书(CCLE)中搜索细胞系,并在癌症基因组图谱(TCGA)中搜索与查询样本基因组特征相似的肿瘤,以研究潜在的有效治疗方法。shinyDeepDR提供了一个交互式界面来解释预测结果并研究单个化合物。总之,shinyDeepDR是一个直观且免费使用的用于抗癌药物筛选的网络工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bd/10873157/e2e6780ab626/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bd/10873157/ceb6ccba9692/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bd/10873157/7d4575d210c0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bd/10873157/1d01866072d3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bd/10873157/e2e6780ab626/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bd/10873157/ceb6ccba9692/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bd/10873157/7d4575d210c0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bd/10873157/1d01866072d3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1bd/10873157/e2e6780ab626/gr3.jpg

相似文献

1
shinyDeepDR: A user-friendly R Shiny app for predicting anti-cancer drug response using deep learning.shinyDeepDR:一款用户友好的R Shiny应用程序,用于使用深度学习预测抗癌药物反应。
Patterns (N Y). 2024 Jan 12;5(2):100894. doi: 10.1016/j.patter.2023.100894. eCollection 2024 Feb 9.
2
Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced Cancer.利用晚期癌症患者腹部和骨盆 CT 图像建立卷积神经网络模型预测股骨近端病理性骨折的研究
Clin Orthop Relat Res. 2023 Nov 1;481(11):2247-2256. doi: 10.1097/CORR.0000000000002771. Epub 2023 Aug 23.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
5
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
6
Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods.使用移动应用程序与其他方法收集的自我管理调查问卷回复的比较。
Cochrane Database Syst Rev. 2015 Jul 27;2015(7):MR000042. doi: 10.1002/14651858.MR000042.pub2.
7
Improving the usability of open health service delivery simulation models using Python and web apps.使用Python和网络应用程序提高开放式医疗服务提供模拟模型的可用性。
NIHR Open Res. 2023 Dec 15;3:48. doi: 10.3310/nihropenres.13467.1. eCollection 2023.
8
PCTA, A PAN-CANCER CELL LINE TRANSCRIPTOME ATLAS.PCTA,一个泛癌种细胞系转录组图谱。
bioRxiv. 2024 Jan 12:2024.01.10.575087. doi: 10.1101/2024.01.10.575087.
9
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

引用本文的文献

1
Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics.将伊曲康唑用于治疗外阴阴道念珠菌病的药物重新用作癌症治疗药物。
Front Pharmacol. 2024 Jun 27;15:1428755. doi: 10.3389/fphar.2024.1428755. eCollection 2024.

本文引用的文献

1
Benchmark of embedding-based methods for accurate and transferable prediction of drug response.基于嵌入的方法在准确和可转移的药物反应预测中的基准测试。
Brief Bioinform. 2023 May 19;24(3). doi: 10.1093/bib/bbad098.
2
Database resources of the National Center for Biotechnology Information in 2023.2023 年国立生物技术信息中心的数据库资源。
Nucleic Acids Res. 2023 Jan 6;51(D1):D29-D38. doi: 10.1093/nar/gkac1032.
3
Annual report to the nation on the status of cancer, part 1: National cancer statistics.国家癌症报告:癌症统计数据 1. 全国癌症统计数据概览
Cancer. 2022 Dec 15;128(24):4251-4284. doi: 10.1002/cncr.34479. Epub 2022 Oct 27.
4
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma.肝细胞癌的分子发病机制和系统治疗。
Nat Cancer. 2022 Apr;3(4):386-401. doi: 10.1038/s43018-022-00357-2. Epub 2022 Apr 28.
5
Delivering precision oncology to patients with cancer.为癌症患者提供精准肿瘤学治疗。
Nat Med. 2022 Apr;28(4):658-665. doi: 10.1038/s41591-022-01717-2. Epub 2022 Apr 19.
6
EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression.EHMT2通过表观遗传沉默APC表达促进肝细胞癌的发病机制。
Cell Biosci. 2021 Aug 3;11(1):152. doi: 10.1186/s13578-021-00663-9.
7
Investigation of REFINED CNN ensemble learning for anti-cancer drug sensitivity prediction.基于精细化 CNN 集成学习的抗癌药物敏感性预测研究。
Bioinformatics. 2021 Jul 12;37(Suppl_1):i42-i50. doi: 10.1093/bioinformatics/btab336.
8
Artificial Intelligence in Cancer Research and Precision Medicine.人工智能在癌症研究和精准医学中的应用。
Cancer Discov. 2021 Apr;11(4):900-915. doi: 10.1158/2159-8290.CD-21-0090.
9
Synthetic Lethality in Cancer Therapeutics: The Next Generation.癌症治疗中的合成致死性:新一代。
Cancer Discov. 2021 Jul;11(7):1626-1635. doi: 10.1158/2159-8290.CD-20-1503. Epub 2021 Apr 1.
10
Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells.利用人类癌细胞深度学习模型预测药物反应和协同作用。
Cancer Cell. 2020 Nov 9;38(5):672-684.e6. doi: 10.1016/j.ccell.2020.09.014. Epub 2020 Oct 22.